Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

IKVAV (H-Ile-Lys-Val-Ala-Val-OH) - CAS 131167-89-0

IKVAV Peptide (H-Ile-Lys-Val-Ala-Val-OH) US$547.30 Excluding tax and shipping fees In stock Description About IKVAV Peptide (H-Ile-Lys-Val-Ala-Val-OH) IKVAV peptide is derived from the α‐1 chain of laminin. IKVAV is a bioactive peptide that can self-assemble i

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

IKVAV Peptide (H-Ile-Lys-Val-Ala-Val-OH)

US$547.30

Excluding tax and shipping fees

In stock

Description

About IKVAV Peptide (H-Ile-Lys-Val-Ala-Val-OH)

IKVAV peptide is derived from the α‐1 chain of laminin. IKVAV is a bioactive peptide that can self-assemble into nanofibers. It is used in neuronal tissue engineering due to its ability to facilitate differentiation of neural progenitor cells into neurons. Rapid differentiation of neural progenitor cells into neurons and neurite outgrowth have been induced by IKVAV biofunctionalized hydrogels. Described by Silva et al. 2004. For research use only, do not use in humans!

IKVAV Peptide (H-Ile-Lys-Val-Ala-Val-OH) - Specifications

Peptide sequence: H-IKVAV-OH (synthetic)

Amount: 20 mg net (AAA)

Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)

Counterion: TFA

Delivery Format: Freeze-dried in plastic vial

MW (average): 528.69000000000005

Application(s): Tissue engineering, Drug delivery

Condition(s)/Topic(s): Regenerative medicine

Standard Delivery Time: 2-5 days

JPT’s Hydrogel Forming Peptides

Peptide-based hydrogels or peptide nanogels stand out due to their biocompatibility and biodegradability, which make them ideal for biomedical applications. These nanogels self-assemble in aqueous solutions without the need for gelators, cross-linkers, or mechanical stimulators, forming hydrogel scaffolds that closely resemble the architecture of the extracellular matrix (ECM). JPT Peptide Technologies has substantial, long-standing expertise in providing peptides in all formats, scales and modifications to the global scientific community. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

All peptides are made in Germany

Bulk orders or custom peptide synthesis upon request

Provision of freeze-dried aliquots for enhanced stability

Proven track record

Need the conjugated or modified peptide? Contact us!

References

References for IKVAV Peptide (H-Ile-Lys-Val-Ala-Val-OH)

References:Read References with Specialty PeptidesTestimonial:"Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source.We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle."Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands

Testimonial:Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source.We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle.Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands

Documentation

Documentation for IKVAV Peptide (H-Ile-Lys-Val-Ala-Val-OH)

IKVAV-Peptide-H-Ile-Lys-Val-Ala-Val-OH.pdf

Properties

Properties of IKVAV Peptide (H-Ile-Lys-Val-Ala-Val-OH)

20 mg net (AAA)

Drug delivery, Tissue engineering

Hydrogel Forming Peptides

Regenerative medicine

Freeze-dried in plastic vial

Human

Self-assembling peptide

Trial Grade: each peptide purified to > 90% (HPLC/MS)

Yes

Further Information to IKVAV Peptide (H-Ile-Lys-Val-Ala-Val-OH)

Values

H-IKVAV-OH (synthetic)

Related Products

Related Products

Fmoc-Phe-Phe-OH (Fmoc-FF )

US$387.40

IVZK - self-assembling peptide

US$618.80

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →